Sbi Securities Co., Ltd. Amneal Pharmaceuticals, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 38 shares of AMRX stock, worth $303. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38Holding current value
$303% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AMRX
# of Institutions
192Shares Held
140MCall Options Held
57KPut Options Held
49K-
Ubs Group Ag21.8MShares$174 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$117 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$98.4 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$90 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$85.6 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.21B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...